GNPX Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
4.5M
+27.7%
3.5M
+5.2%
3.3M
-28.5%
4.7M
+18.0%
4.0M
R&D
2.7M
+25.0%
2.2M
+0.2%
2.2M
-12.3%
2.5M
-1.6%
2.5M
SG&A
1.7M
+32.2%
1.3M
+14.7%
1.2M
-47.2%
2.2M
+52.7%
1.4M
Operating Income
-4494184
-27.7%
-3518632
-5.2%
-3345913
+28.5%
-4681784
-18.0%
-3969292
EBITDA
-4494184
-27.7%
-3518632
-5.2%
-3345913
+28.5%
-4681784
-18.0%
-3969292
Net Income
-4461895
-17.7%
-3790211
+0.2%
-3799240
+18.7%
-4674901
-17.9%
-3964601
EPS (Basic)
$-14.08
+64.3%
$-39.46
+64.1%
$-110.00
+41.2%
$-187.00
+34.5%
$-285.56
EPS (Diluted)
$-14.08
+64.3%
$-39.46
+64.1%
$-110.00
+41.2%
$-187.00
+34.5%
$-285.56
Shares (Diluted)
316.0K
+229.0%
96.1K
+177.9%
34.6K
+37.8%
25.1K
+80.8%
13.9K
Genprex (GNPX) โ€” Financials